ArticleDalton transactions (Cambridge, England : 2003)2017

cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.

Gabriel E Büchel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.